Adiponectin analogue (Allysta Pharmaceuticals)

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameAdiponectin analogue (Allysta Pharmaceuticals)
Drug Alias NameAdiponectin peptide analog (Allysta Pharmaceuticals)ALY-732ALY-688ADP-355ALY-688-SR
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAdiponectin receptors agonists
TargetsAdiponectin receptors
Therapy Area/IndicationsOverweightObesityDry Eye Syndromes +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllysta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllysta Pharmaceutical
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsOverweightObesityDry Eye Syndromes

Other Information

ATC CodeN/A
Related LinksN/A